Maternal Bile Acid Profile and Subtype Analysis of Intrahepatic Cholestasis of Pregnancy

Yong Shao,Huan Li,Qing-Nan Tang,Di Xu,Siyu Chen

DOI: https://doi.org/10.2139/ssrn.3543582

2020-01-01

SSRN Electronic Journal

Abstract:Background: To investigate the characteristics of serum bile acid spectrum of pregnant women with different subtypes of intrahepatic cholestasis of pregnancy (ICP). Methods: 144 cases of ICP patients were involved in this study, and were divided into four subgroups according to serum TBA, DBIL, and ALT. UPLC-MS/MS was used to dectect 15 bile acids. Findings ①The differential serum bile acid profiles of ICP group and normal pregnant women were DCA, TDCCA, TCA, GDCA and GLCA.②The differential serum bile acid profiles of the ICP1 group (ICP with jaundice) and normal pregnant women were TCDCA, TCA, GCA, GCDCA, TUDCA and GUDCA, and the ICP1 group was significantly higher than normal pregnant group (P <0.05).③The differential serum bile acid profiles of the ICP3 group (hyperbiliary acidemia of pregnancy) and normal pregnant group was GUDCA, LCA, GLCA, UDCA, TUDCA, CDCA, and TLCA (P <0.05).④The differential serum bile acid profiles of ICP4 group (idiopathic aminotransferase abnormality during pregnancy) and normal pregnant group was UDCA, GUDCA, TUDCA, GCA and GLCA (P <0.05).⑤The occurrence of meconium-stained amniotic fluid, premature delivery and cesarean section in ICP1 group was significantly higher than normal group,ICP2 group,ICP3 group,and ICP4 group (P <0.05); The occurrence of meconium-stained amniotic fluid, premature delivery and cesarean section in ICP2 group, ICP3 group,and ICP4 group was significantly higher than normal group (P <0.05), but no difference was found among ICP2 group, ICP3 group,and ICP4 group (P> 0.05). Interpretations: Maternal serum bile acid profiles are useful to differentiate the four subtypes of ICP. ICP with jaundice could be an important predictor of adverse pregnancy outcomes of ICP. Funding Statement: National Natural Sciences Foundation of China (No. 81471473) and Chongqing Health Planning Commission project (No. 2019ZDXM055).Declaration of Interests: The authors stated that no conflict of interest can be declared.Ethics Approval Statement: This study obtained the informed consent of all subjects, and was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University.